Cytochrome P450 enzyme activities in the Australian brushtail possum Trichosurus vulpesula: A comparison with the rat, rabbit, sheep and chicken

Veterinary and Human Toxicology

Volumn 40, Issue 2, 1998, Pages 70-76

  Olkowski, Andrzej ^a   Gooneratne, Ravi ^a   Eason, Charles ^b  

^a LINCOLN UNIVERSITY   (New Zealand)

^b LANDCARE RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANILINE DERIVATIVE; COUMARIN; CYTOCHROME B5; CYTOCHROME P450; CYTOCHROME REDUCTASE; MICROSOME ENZYME; N DEMETHYLASE; PHENACETIN; XENOBIOTIC AGENT;

ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CHICKEN; ENZYME ACTIVITY; ENZYME KINETICS; HYDROXYLATION; LIVER MICROSOME; MALE; NEW ZEALAND; NONHUMAN; OPOSSUM; RABBIT; RAT; SHEEP; SPECIES DIFFERENCE;

ANIMALS; BIOTRANSFORMATION; CHICKENS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; MALE; MICROSOMES, LIVER; NADH, NADPH OXIDOREDUCTASES; NADPH-FERRIHEMOPROTEIN REDUCTASE; NEW ZEALAND; OPOSSUMS; PEST CONTROL; RABBITS; RATS; SHEEP; SPECIES SPECIFICITY; XENOBIOTICS;

EID: 0031894698     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. King CM: Order Chiroptera. In King CM Ed: The Handbock of New Zealand Mammals, Oxford University Press, Auckland, 1990.
2. Coleman JD: Distribution, prevalence, and epidemiology of bovine tuberculosis in brushtail possum, Trichosurus vulpecula in the Hohonu Range, New Zealand. Aust Wild Res 15: 651-663, 1988.
3. Cowan PE: Denning habits of common brushtail possums, Trichosurus vulpecula, in New Zealand lowland forest. Aust Wild Res 16: 63-78, 1989.
4. Livingstone PC: Tuberculosis in New Zealand-current status and control policies. Surveillance-Wellington 19: 14-18, 1992.
5. Livingstone PC: The use of 1080 in New Zealand. In Seawright AA, Eason CT Eds: Proceedings of the Science Workshop on 1080. The Royal Society of New Zealand, Miscellaneous Series 28: 1-10, 1994.
6. Nelson DR, Koymans L, Kamataki T et al : P450 superfamily: Update on new sequences, gene mapping, accession and nomenclature. Pharmacogenetics 6: 1-42, 1996.
7. Nebert OW, Adesnik M, Coon MJ et al : The P450 gene superfamily: Recommended nomenclature. DNA 6: 1-11, 1987.
8. Gonzalez FJ: Molecular genetics of the P450 superfamily. Pharmacol Ther 45: 1-38, 1990.
9. Turner JC: Cyanide detoxication in the possum Trichosurus vulpecula. NZ J Sci 12: 569-575, 1969.
10. Bell J : The acute toxicity of four common poisons to the opossum, Trichosurus vulpecual. NZ Vet J 20: 212-214, 1972.
11. McManus ME, IIett KF: Microsomal xenobiotic metabolism in marsupials. Drug Metab Dispo 5: 503-509, 1977.
12. McLean S, Galloway H, Butler S et al : Acetylation of sulphanilamide in four marsupials and a monotreme. Xenobiotica 13: 81-85, 1983.
13. Awauddin AB, McLean S : Conjugation of benzoic acid in marsupials. Aust J Zool 33: 693-698, 1985.
14. Klassen CD, Atndur MO, Doull J: Casarett and Doull's Toxicology, 5th Ed. Me Craw-Hill, New York, 1996.
15. Cuengerich FP: Analysis and characterization of enzymes. In Hayes WA Ed: Principles and Methods of Toxicology, 2nd Ed. Raven Press, New York, 1989.
16. Omura T, Sato R: The carbon monoxide-binding pigment in liver microsomes: I Evidence for its hemoprotein nature. J Biol Chem 239: 2370-2378, 1964.
17. Omura T, Sato R: The carbon monoxide-binding pigment of liver microsomes: II Solubi1ization, purification and properties. J Biol Chem 239: 2379-2385, 1964.
18. Strobel HW, Digman JD: Purification and properties of NADPH-cytochrome P450 reductase. In Fleisher S, Packer A Eds: Methods in Enzymology 52: 89-92, 1978.
19. Wilkinson GN: Statistical estimations in enzyme kinetics. Biochem J 80: 324-332, 1961.
20. Snedecor GW, Cochran WG: Statistical Methods, 8th Ed. Iowa State University Press, Ames, Iowa, 1989.
21. Murray M, Reidy GF: Selectivity in the inhibition of mammalian cytochrome P450 by chemical agents. Pharmacol Rev 42: 85-101, 1990.
22. Ruckpaul K, Rein H, Blanck J: Regulation of the activity of the hepatic endoplasmic cytochrome P450. In Ruckpaul K, Rein H Eds: Basic Mechanisms of Regulation of Cytochrome P450. Taylor & Francis, London, 1989.
23. Fentem JH, Fry JR: Species differences in the metabolism and hepatotoxicity of coumarin. Comp Biochem Physiol C 104: 1-8, 1993.
24. Sutcliffe FA, McNicoll AD, Gibson GG: Aspects of anticoagulant action: A review of the pharmacology, metabolism, and toxicology of warfarin and congeners. Rev Drug Metab Drug Interact 5: 225-302, 1987.
25. Eason CT, Framptom CN, Henderson R et al : Sodium monofluoroacetate and alternative toxins for possum control. NZ J Zool 20: 329-334, 1993.
26. McGirr JL, Papworth OS: The toxicity of rodenticides, I. Sodium fluoroacetate, ANTU, and warfarin. Vet Rec 67: 124, 1955.
27. Papworth DS: A review of the dangers of warfarin poisoning to animals and other rodents. Royal Society Promotion Health Journal 78: 52, 1958.
28. Ono S, Hatanaka T, Holta H et al : Specificity of substrate and inhibitor probes for cytochrome P450s: Evolution of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26: 681-693, 1996.
29. Correia MA: Rat and human liver cytochrome P450: Substrate and inhibitor specificities and functional markers. In Oritz de Montellano PR Ed: Cytochrome P450: Structure, Mechanism and Biochemistry, 2nd Ed. Plenum Press, New York: 607-627, 1995.
30. Fentem JH, Fry JR: Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbi1 and rat hepatic microsomal monooxygenase activities. Xenobiotica 21: 895-904, 1991.
31. Smith DA: Species differences in metabolism and pharmacokinetics: Are we close to an understanding? Drug Metab Rev 23: 355-373, 1991.
32. Boobis AR, Murray S, Speirs J et al : In Benford DJ, Bridges JW, Gibson C et al Eds: Drug Metabolism, from Molecules to Man. Taylor & Francis, London: 352-368, 1987.
33. Boobis AR, Brodie MJ, Kahn GC et al : Comparison of the in vivo and in vitro rates of formation of the three main metabolites of antipyrine in man. Brit J Clin Pharmacol 12: 771-777, 1981.
34. Brodie MJ, Boobis AR, Bulpitt CJ et al : Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol 20: 39-46, 1981.
35. McPherson GAD, Benjamin IS, Boobis AR et al : Antipyrine elimination as a dynamic test of hepatic integrity in obstructive jaundice. Gut 23: 734-738, 1982.